J Am Coll Cardiol 2024;84:1646-62.PubMed 98
Patients without urgent medical complications requiring immediate weight loss Those who tried semaglutide and found weight loss insufficient Individuals seeking maximum possible weight loss approaching surgical levels Patients who experienced intolerable nausea on Ozempic Those participating in or eligible for clinical trials Current Ozempic patients wondering about switching present a nuanced situation
The Wegovy pill is FDAapproved to reduce the risk of major cardiovascular events, such as heart attack, stroke, or death in adults with obesity or overweight who also have established heart disease along with a reduced-calorie diet and increased physical activity
Primary care patients: The simplicity of an oral tablet taken once daily at any time, without fasting requirements or SNAC absorption enhancer restrictions, aligns with primary care prescribing patterns
They are supplied for laboratory and scientific research purposes only and are not supplied as medicines, treatments, prescriptions or personal-use products
